The U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) to the Oticon Medical's Neuro System to treat individuals 18 years or older, with bilateral severe-to-profound sensorineural hearing loss, who obtain limited benefit from appropriately fitted hearing aid(s).